KVP Capital Advisors »

Soleno Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 60k 46.30

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
State Street Corporation
venBio Select Advisor
Wellington Management Company
Vivo Capital
Invesco
Caption Management
Adage Capital Partners GP
Commodore Capital
Millennium Management
Polar Capital Holdings
Braidwell

View all funds holding Soleno Therapeutics